Figure 1From: An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic riskOverall schema of analysis plan. Blue boxes show the assay platform advancement and the developmental progression of ICS as a prognostic biomarker (discovery, validation and optimization). Black boxes show the signatures assessed at each stage of development.Back to article page